Stability of metronidazole, tetracycline HCl and famotidine alone and in combination

International Journal of Pharmaceutics

Volumn 290, Issue 1-2, 2005, Pages 1-13

  Wu, Yunqi ^a   Fassihi, Reza ^b  

^a Product Development   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Compatibility; Drug combinations; Famotidine; Metronidazole; pH solubility; Stability; Tetracycline HCl

Indexed keywords

FAMOTIDINE; METRONIDAZOLE; TETRACYCLINE;

ARTICLE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HIGH TEMPERATURE; HUMIDITY; LIGHT EXPOSURE; LIQUID; PH; PREFORMULATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLID;

DRUG COMBINATIONS; DRUG STABILITY; FAMOTIDINE; METRONIDAZOLE; SOLUBILITY; TETRACYCLINE;

EID: 12344335757     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.10.015     Document Type: Article

References (29)

1. S.L. Ali Tetracycline K. Florey Analytical Profiles of Drug Substances vol. 5 1976 Academic Press New York 597 653
2. M. Bakshi, and S. Singh Stress degradation studies on metronidazole and development of a validated stability-indicating HPLC assay method Pharm. Technol. 2003 148 160
3. D.H. Balaban, and D.A. Peura J.T. LaMont Gastrointestinal Infections, Diagnosis and Management 1997 Marcel Dekker New York 29 69
4. D.G. Cooper, R.C. Young, G.J. Durant, and C.R. Ganellin C. Hansch Comprehensive Medicinal Chemistry: The Rational Design, Mechanistic Study and Therapeutic Application of Clinical Compounds vol. 3 1990 Pergamon Press New York 323 421
5. C.J. Corrall II C.R. Craig R.E. Stitzel Modern Pharmacology with Clinical Applications 5th ed 1997 Little, Brown and Company Boston 579 582
6. M.P. Dore, D.Y. Graham, R. Mele, L. Marras, S. Nieddu, A. Manca, and G. Realdi Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection Am. J. Gastroenterol. 97 2002 857 860
7. P.O. Erah, A.F. Goddard, D.A. Barrett, P.N. Shaw, and R.C. Spiller The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection J. Antimicrob. Chemoth. 39 1997 5 12
8. Faigel, D.O., Melnyk, C., 1999. Brandt, L.J. (Ed.), Clinical Practice of Gastroenterology, vol. 1, Churchill Livingstone, Current Medicine, Philadelphia, pp. 264-272.
9. D.P. Healy, R.J. Dansereau, A.B. Dunn, C.E. Clendening, A.W. Mounts, and G.S. Deepe Jr. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate Ann. Pharmacother. 31 1997 1460 1464
10. C.W. Howden G. Friedman Gastrointestinal Pharmacology and Therapeutics 1997 Lippincott-Raven Publishers Philadelphia 45 54
11. R.N. Jones, M.A. Pfaller, and M.G. Cormican 4th ed. T.M. Speight N.H.G. Holford Avery's Drug Treatment vol. 1471 1997 Adis Press Auckland 1465 1466
12. L. Karalliedde, and J.A. Henry Handbook of Drug Interactions 1998 Arnold London p. 331
13. C.F. Lacy, L.L. Armstrong, M.P. Goldman, and L.L. Lance Drug Information Handbook 8th ed 2001 Lexi-Comp, Inc. Hudson pp. 479-480
14. P. Malferteiner Moderator's introduction. IV. Management of Helicobacter pylori-positive peptic ulcer disease Scand. J. Gastroenterol. 31 S215 1996 69
15. P. Malfertheiner, and J.W. Freston G. Friedman Gastrointestinal Pharmacology and Therapeutics 1997 Lippincott-Raven Publishers Philadelphia 21 29
16. A. Martin Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences 4th ed 1993 Williams & Wilkins Baltimore
17. M. Mayersohn G.S. Banker C.T. Rhodes Modern Pharmaceutics, Revised and Expanded 3rd ed 1996 Marcel Dekker New York 21 73
18. D. Moreau Physician's Drug Handbook 6th ed 1995 Springhouse Corporation Springhouse pp. 662-664, 965-968
19. P.R. Murray, K.S. Rosenthal, G.S. Kobayashi, and M.A. Pfaller M. Brown Medical Microbiology 3rd ed 1998 Mosby St. Louis pp. 165-167, 254-257
20. H. Nyqvist Saturated salt solutions for maintaining specified relative humidities Int. J. Pharm. Technol. Prod. Manuf. 4 1983 47 48
21. D.W. Piper, D.J. De Carle, N.J. Talley, N.D. Gallagher, J.S. Wilson, L.W. Powell, D. Crawford, P.R. Gibson, T.C. Sorrell, J.E. Kellow, and R.K. Roberts T.M. Speight N.H.G. Holford Avery's Drug Treatment 4th ed 1997 Adis Press Auckland 933 1021
22. L.W. Scheibel, and K.V. Dyke C.R. Craig R.E. Stitzel Modern Pharmacology with Clinical Applications 5th ed 1997 Little, Brown and Company Boston 635 636
23. J. Schrefer, and D. Nissen Mosby's GenRx: A Comprehensive Reference for Generic and Brand Prescription Drugs 11th ed 2001 Mosby St. Louis
24. K. Seppala, T.U. Kosunen, H. Nuutinen, P. Sipponen, H. Rautelin, S. Sarna, H. Hyvarinen, M. Farkkila, and T.A. Miettinen Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients Scand. J. Gastroenterol. 35 2000 929 934
25. The Merck Index, 2001. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th ed. Merck & Co., Inc., Whitehouse Station.
26. P. Unge Review of Helicobacter pylori eradication regimes Scand. J. Gastroenterol. 31 1996 74 81
27. E.-J. Van der Wouden, J.C. Thijs, J.G. Kusters, A.A. Van Zwet, and J.H. Kleibeuker Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori Scand. J. Gastroenterol. 36 2001 10 14
28. L.L. Wearley, and G.D. Anthony K. Florey Analytical Profiles of Drug Substances vol. 13 1984 Academic Press Orlando 327 344
29. J.D.C. Yao, and R.C. Moellering Jr. P.R. Murray Manual of Clinical Microbiology 7th ed 1999 ASM Press Washington, DC pp. 1485-1486, 1492-1493